A Clinical Trial of TQC3927 Powder for Inhalation in Chronic Obstructive Pulmonary Disease

NCT06711991 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: TQC3927 powder for inhalation
DRUG: TQC3927 powder for inhalation placebo

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.